New
HealthMore in Health →
Europe’s green light for Fractyl’s GLP-1 gene therapy test marks a new front in obesity medicine
European regulators have cleared Fractyl Health to begin what the source describes as the first clinical test of a GLP-1 gene therapy. The decision signals how aggressively drug developers are pursuing alternatives to长期?
Key Takeaways
- European regulators cleared Fractyl Health to begin a clinical test of a GLP-1 gene therapy.
- The source describes it as the first clinical test of its kind.
DE
DT Editorial AI··via endpoints.news